Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD.
about
Curcumin for maintenance of remission in ulcerative colitisDietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitisAnti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.Diet in the pathogenesis and treatment of inflammatory bowel diseasesCurcumin inhibits interferon-γ signaling in colonic epithelial cells.NRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction.Nightmare Frequency, Nightmare Distress and the Efficiency of Trauma-Focused Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder.Therapeutic potential of curcumin in gastrointestinal diseases.Bone, inflammation, and inflammatory bowel disease.Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkersTherapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?Immune modulation by curcumin: The role of interleukin-10.Healing effect of pistacia atlantica fruit oil extract in acetic Acid-induced colitis in rats.Protective Effect of Curcumin Against Acute Ultraviolet B Irradiation-induced Photo-damage.Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells.Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.Role of Curcumin in Disease Prevention and Treatment.Prevention of iron- and copper-mediated DNA damage by catecholamine and amino acid neurotransmitters, l-DOPA, and curcumin: metal binding as a general antioxidant mechanism
P2860
Q24198106-4C6E4FCD-BEE3-4EA3-892B-458DA9E24F6DQ27021100-6D330A74-F931-4F3D-B938-444D8E9D97FFQ33769533-666418A4-1920-4B85-B3E5-20DAA5F836F6Q35537121-0ADD518F-E471-4C19-9793-FDA82E1CFC2DQ35939370-65480BBE-ADBA-4688-8077-61CDFD8DB04CQ36678635-6B10D5DE-7B2A-4005-B038-9B8C6C39A670Q37364056-0CE8C94A-A88F-4B5B-B5E7-B6A4B6645096Q37878888-C81F4D9F-3706-4720-89C1-096935D16220Q37936285-A7AAD03F-BD63-49C5-A923-ECF87E4C3D9DQ38083084-DDBADA7C-413C-4A11-BE3D-C94AFAF07EDFQ39069841-DB437116-1DD1-4D1D-A402-A8496A26446FQ40097338-4D9F0878-1A13-47AE-B2EB-F6D75E0B99EEQ43029204-CF457317-585A-42EC-A064-F5BAB193DE83Q46503193-5BA5C985-8BD0-44B5-9B63-8DAC4A4D0A30Q52638791-8D3212CD-ECA0-406A-B02F-B1622D83C3F6Q55057352-D7995639-CF7E-4615-BA44-4DE29291E122Q55237808-B9282927-7498-42D6-8D0E-DB3727528F27Q58046816-D167C050-65AB-4B1A-83F9-287A8EC0A571
P2860
Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Oral administration of curcumi ...... -deficient mouse model of IBD.
@en
Oral administration of curcumi ...... -deficient mouse model of IBD.
@nl
type
label
Oral administration of curcumi ...... -deficient mouse model of IBD.
@en
Oral administration of curcumi ...... -deficient mouse model of IBD.
@nl
prefLabel
Oral administration of curcumi ...... -deficient mouse model of IBD.
@en
Oral administration of curcumi ...... -deficient mouse model of IBD.
@nl
P2093
P2860
P921
P1476
Oral administration of curcumi ...... -deficient mouse model of IBD.
@en
P2093
Beate C Sydora
Jason S G Doyle
Rae R Foshaug
Sarah M MacFarlane
Thomas A Churchill
Victoria Y L Ung
P2860
P2888
P304
P356
10.1007/S10620-009-0843-Z
P577
2009-06-10T00:00:00Z
P5875
P6179
1035874195